Reminder Messages for Lung Cancer Screening
Study tests reminder messages to boost lung cancer screening
Plain English Summary
Reminder Messages for Lung Cancer Screening is a Not Applicable clinical trial sponsored by M.D. Anderson Cancer Center studying Skin Flaps, Lung Cancer. This study is testing different ways to remind people to get screened for lung cancer. It's for adults aged 40-80 who currently smoke or have a history of smoking. Participants will receive reminder messages and may be asked to share their thoughts on them. There are no alternative treatments being tested; the focus is on improving screening rates. The trial aims to enroll 133 participants.
Official Summary
To test lung cancer screening reminder messages to help adults who 1) 50 to 80 years of age, 2) smoke or have smoked, and 3) do not have history of lung cancer by self-report.
Who Can Participate
Here is what you need to know about eligibility for this trial. You can join if you are between 40 and 80 years old. You must currently smoke or have smoked in the past. You should be able to speak English or Spanish, or be a caregiver/family member of someone who has used tobacco. You cannot join if you have a history of lung cancer. This trial is studying Skin Flaps, Lung Cancer, so participants generally need a confirmed diagnosis.
What They're Measuring
The study will measure how acceptable and useful people find the reminder messages, indicating how likely they are to encourage lung cancer screening. The specific primary outcome measures are: Ottawa Acceptability questionnaires (through study completion; an average of 1 year). These endpoints are how researchers determine whether the treatment is effective and will form the basis of any future regulatory submissions.
About This Phase
This study does not have a traditional clinical phase designation. It may be an observational study that follows patients without intervening in their care, an expanded access or compassionate use program, or other non-interventional research. These studies contribute valuable data about disease progression, treatment patterns, and patient outcomes.
Why This Trial Matters
This trial aims to improve lung cancer detection by making screening more accessible through effective reminder systems, addressing a gap in early diagnosis. This research targets Skin Flaps, Lung Cancer, where improved treatment options are needed.
Investor Insight
This observational study focuses on patient engagement for a critical screening program, suggesting potential for improved adherence and early detection in a large at-risk population.
Is This Trial Right for Me?
Ask your doctor if lung cancer screening is right for you, especially if you meet the age and smoking history criteria. Participation involves receiving reminder messages and potentially providing feedback through surveys or interviews. The time commitment is about 1 year, with most activities done remotely. The trial is being conducted at 1 site. Always discuss clinical trial participation with your healthcare provider before making any decisions. This information is for educational purposes only and is not medical advice.
AI-generated analysis for educational purposes only. This is not medical advice. Discuss clinical trial participation with your doctor. Data sourced from ClinicalTrials.gov.
Study Design
- Study Type: OBSERVATIONAL
- Enrollment: 133 participants
Primary Outcomes
- Ottawa Acceptability questionnaires (through study completion; an average of 1 year)
Full Eligibility Criteria
Inclusion Criteria: * Adults ages 40-80 years * Currently use combustible tobacco products or used combustible tobacco products in the past * English or Spanish speaker (based on self-report) Or an adult caregiver/care partner or family member of someone with a history of combustible tobacco product use (may participate in focus groups, cognitive interviews, surveys) Exclusion Criteria: • History of lung cancer (based on self-report)
Trial Locations
- M D Anderson Cancer Center, Houston, Texas, United States
Frequently Asked Questions
What is clinical trial NCT05952778?
NCT05952778 is a Not Applicable OBSERVATIONAL study titled "Reminder Messages for Lung Cancer Screening." It is currently active, not recruiting and is sponsored by M.D. Anderson Cancer Center. The trial targets enrollment of 133 participants.
What conditions does NCT05952778 study?
This trial investigates treatments for Skin Flaps, Lung Cancer. The primary condition under study is Skin Flaps.
What does Not Applicable mean for NCT05952778?
This study does not have a defined clinical phase. It may be an observational study, expanded access program, or other non-interventional research.
What is the current status of NCT05952778?
This trial is currently "Active, Not Recruiting." It started on 2023-06-20. The estimated completion date is 2029-12-31.
Who is sponsoring NCT05952778?
NCT05952778 is sponsored by M.D. Anderson Cancer Center. The sponsor is responsible for funding, designing, and overseeing the clinical trial.
How many people can participate in NCT05952778?
The trial aims to enroll 133 participants. The trial status is active, not recruiting.
How is NCT05952778 designed?
This is a observational study.
What are the primary outcomes being measured in NCT05952778?
The primary outcome measures are: Ottawa Acceptability questionnaires (through study completion; an average of 1 year). These are the main endpoints researchers use to determine whether the treatment is effective.
Where is NCT05952778 being conducted?
This trial is being conducted at 1 site, including Houston, Texas (United States).
Where can I find official information about NCT05952778?
The official record for NCT05952778 is available on ClinicalTrials.gov at https://clinicaltrials.gov/study/NCT05952778. This government database provides the most up-to-date and detailed information about the trial.
What is NCT05952778 testing in simple terms?
This study is testing different ways to remind people to get screened for lung cancer. It's for adults aged 40-80 who currently smoke or have a history of smoking.
Why is this trial significant?
This trial aims to improve lung cancer detection by making screening more accessible through effective reminder systems, addressing a gap in early diagnosis.
What are the potential risks of participating in NCT05952778?
The main risk is the potential for anxiety or distress related to lung cancer screening results. Side effects are minimal as this is an observational study; the focus is on communication, not medical intervention. As with any clinical trial, participants are closely monitored and can withdraw at any time.
Should I consider participating in NCT05952778?
Ask your doctor if lung cancer screening is right for you, especially if you meet the age and smoking history criteria. Participation involves receiving reminder messages and potentially providing feedback through surveys or interviews. The time commitment is about 1 year, with most activities done remotely. Always discuss clinical trial participation with your healthcare provider to determine if it is appropriate for your specific situation.
What does NCT05952778 signal from an investment perspective?
This observational study focuses on patient engagement for a critical screening program, suggesting potential for improved adherence and early detection in a large at-risk population. This is a Not Applicable trial, which is in early development stages.
What happens if the treatment in this trial doesn't work?
Participants will receive reminder messages and may be asked to share their thoughts on them. Participants in clinical trials always have the right to withdraw and pursue alternative treatments. The study team will help transition patients to other available options.
Related Conditions
More Skin Flaps Trials
This analysis is AI-generated and does not constitute medical advice. Always consult your healthcare provider before making decisions about clinical trial participation.